Subsyde-CR

Subsyde-CR

diclofenac

Manufacturer:

Raptakos Brett

Distributor:

Raptakos Brett
Concise Prescribing Info
Contents
Diclofenac Na
Indications/Uses
Inflammatory & degenerative forms of rheumatism, RA, ankylosing spondylitis, OA & spondyloarthritis; painful syndromes of the vertebral column, nonarticular rheumatism, painful posttraumatic & post-op inflammation & swelling eg, following orthopedic or dental surgery, painful & inflammatory conditions in gynecology. Adjuvant in severe painful inflammatory infections of the ENT eg, otitis.
Dosage/Direction for Use
Administration
Should be taken with food: Take preferably between 6-8 p.m.
Contraindications
Hypersensitivity. Peptic ulcer, asthma, urticaria or acute rhinitis.
Special Precautions
Patients w/ GI disorders, history suggestive of peptic ulcer, ulcerative colitis or Crohn's disease & severely impaired hepatic function. Monitor hepatic function during prolonged treatment. Severe hepatic impairment. Impaired cardiac or renal function. Pregnancy (3rd trimester) & lactation. Childn. Elderly.
Adverse Reactions
Occasional epigastric pain, other GI symptoms eg, nausea, vomiting, diarrhea, abdominal cramps, dyspepsia, flatulence & anorexia; headache, dizziness, vertigo; skin rash; elevated SGOT & SGPT.
Drug Interactions
Aspirin; anticoagulants, digoxin, methotrexate, cyclosporine; lithium. Hypoglycemic & hyperglycemic reactions w/ oral hypoglycemics. May raise serum K levels w/ K-sparing diuretics.
ATC Classification
M01AB05 - diclofenac ; Belongs to the class of acetic acid derivatives and related substances of non-steroidal antiinflammatory and antirheumatic products.
Presentation/Packing
Form
Subsyde-CR cap 100 mg
Packing/Price
100's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in